Treatment Sequencing in Advanced RCC: From Evidence to Clinical Practice

Pedro Barata, MD, MSc, and Benjamin Garmezy, MD, discuss the evolving treatment landscape for advanced renal cell carcinoma.

EP. 1: Overview of Renal Cell Carcinoma

March 17th 2023

Pedro Barata, MD, MSc, and Benjamin Garmezy, MD, open the discussion with an overview of renal cell carcinoma.

EP. 2: Renal Cell Carcinoma Histology and Risk Stratification

March 17th 2023

Experts on renal cell carcinoma describe the RCC histologies and tools used for risk stratification.

EP. 3: Patient Profile: A 67-Year-Old Man With Metastatic Clear Cell RCC

March 24th 2023

Benjamin Garmezy, MD, presents the case of a 67-year-old man diagnosed with advanced renal cell carcinoma.

EP. 4: Front Line Trials in Advanced RCC

March 24th 2023

Renal cell carcinoma experts discuss clinical trials, evaluating immunotherapies and tyrosine kinase inhibitors in the front line setting of advanced RCC.

EP. 5: Considerations in Advanced RCC Treatment Selection

March 31st 2023

Pedro Barata, MD, MSc, and Benjamin Garmezy, MD, outline factors taken into consideration when selecting advanced RCC treatments.

EP. 6: Advanced RCC Treatment Options Post-Progression

March 31st 2023

Experts on renal cell carcinoma discuss post-progression treatment options for RCC.

EP. 7: TIVO-3 Trial: Tivozanib for Patients With Advanced RCC

April 7th 2023

A comprehensive overview of the TIVO-3 trial, which compared tivozanib with sorafenib in patients with advanced renal cell carcinoma.

EP. 8: Advanced RCC Treatments Following Prior Immune Checkpoint Inhibitors

April 7th 2023

Drs Barata and Garmezy give detailed thoughts on treating patients with advanced RCC who have received prior immune checkpoint inhibitors.

EP. 9: Clinical Pearls for Treating Advanced Renal Cell Carcinoma

April 14th 2023

Pedro Barata, MD, MSc, and Benjamin Garmezy, MD, close their discussion with clinical pearls for community oncologists treating patients with advanced RCC.